David A. Santos

2020

In 2020, David A. Santos earned a total compensation of $1.2M as Executive Vice President and Chief Commercial Officer at Rigel Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$819,854
Option Awards$155,625
Salary$163,726
Other$51,397
Total$1,190,602

Santos received $819.9K in non-equity incentive plan, accounting for 69% of the total pay in 2020.

Santos also received $155.6K in option awards, $163.7K in salary and $51.4K in other compensation.

Rankings

In 2020, David A. Santos' compensation ranked 7,867th out of 13,090 executives tracked by ExecPay. In other words, Santos earned more than 39.9% of executives.

ClassificationRankingPercentile
All
7,867
out of 13,090
40th
Division
Manufacturing
3,331
out of 5,621
41st
Major group
Chemicals And Allied Products
1,350
out of 2,254
40th
Industry group
Drugs
1,172
out of 1,954
40th
Industry
Pharmaceutical Preparations
874
out of 1,459
40th
Source: SEC filing on April 6, 2021.

Santos' colleagues

We found four more compensation records of executives who worked with David A. Santos at Rigel Pharmaceuticals in 2020.

2020

Raul Rodriguez

Rigel Pharmaceuticals

Chief Executive Officer

2020

Dean Schorno

Rigel Pharmaceuticals

Chief Financial Officer

2020

Dolly Vance

Rigel Pharmaceuticals

Executive Vice President, Corporate Affairs, General

2020

Wolfgang Dummer

Rigel Pharmaceuticals

Chief Medical Officer

News

You may also like